Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernardo Bonanni

Showing results (21-30 of 265) with videos related to

Pageof 27
Sort By:
Oncology Letters|February 14, 2018
<i>BRCA1</i> homozygous unclassified variant in a patient with non-Fanconi anemia: A case reportDavide Bondavalli, Francesca Malvestiti, Valeria Pensotti, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 28, 2019
Familial lobular breast cancer: Is testing for germline CDH1 mutations necessary?Giovanni Corso, Virgilio Sacchini, Gabriella Pravettoni, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|March 24, 2018
The Italian Ministry of Health promotes more than 300 research projects to improve cancer prevention, treatment, and prognosisGiovanni Corso, Debora Macis, Paolo Veronesi, et al.
Current Cancer Drug Targets|June 13, 2009
Biomarkers for risk assessment and prevention of breast cancerMassimiliano Cazzaniga, Andrea Decensi, Bernardo Bonanni, et al.
Oncology Letters|August 28, 2018
Erratum: <i>BRCA1</i> homozygous unclassified variant in a patient with non-Fanconi anemia: A case reportDavide Bondavalli, Francesca Malvestiti, Valeria Pensotti, et al.
Journal of Mammary Gland Biology and Neoplasia|November 1, 2003
Breast cancer prevention trials using retinoidsAndrea Decensi, Davide Serrano, Bernardo Bonanni, et al.
Plos One|April 8, 2022
A randomized controlled trial comparing self-referred message to family-referred message promoting men's adherence to evidence-based guidelines on BRCA1/2 germline genetic testing: A registered study protocolSerena Petrocchi, Giulia Ongaro, Mariarosaria Calvello, et al.
Nature Clinical Practice. Oncology|January 30, 2007
Fenretinide and risk reduction of second breast cancerAndrea Decensi, Silvia Zanardi, Alessandra Argusti, et al.
Current Oncology (Toronto, Ont.)|April 21, 2022
Psychological Determinants of Men's Adherence to Cascade Screening for <i>BRCA1/2</i>Giulia Ongaro, Serena Petrocchi, Mariarosaria Calvello, et al.
American Journal of Men'S Health|August 7, 2025
Can Family Motivation Enhance Men's Uptake of Cascade Screening for Familial <i>BRCA1/2</i> Mutations?Giulia Ongaro, Serena Petrocchi, Mariarosaria Calvello, et al.
Pageof 27

Showing results (21-30 of 265) with videos related to

Sort By:
Pageof 27
Oncology Letters|February 14, 2018
<i>BRCA1</i> homozygous unclassified variant in a patient with non-Fanconi anemia: A case reportDavide Bondavalli, Francesca Malvestiti, Valeria Pensotti, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 28, 2019
Familial lobular breast cancer: Is testing for germline CDH1 mutations necessary?Giovanni Corso, Virgilio Sacchini, Gabriella Pravettoni, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|March 24, 2018
The Italian Ministry of Health promotes more than 300 research projects to improve cancer prevention, treatment, and prognosisGiovanni Corso, Debora Macis, Paolo Veronesi, et al.
Current Cancer Drug Targets|June 13, 2009
Biomarkers for risk assessment and prevention of breast cancerMassimiliano Cazzaniga, Andrea Decensi, Bernardo Bonanni, et al.
Oncology Letters|August 28, 2018
Erratum: <i>BRCA1</i> homozygous unclassified variant in a patient with non-Fanconi anemia: A case reportDavide Bondavalli, Francesca Malvestiti, Valeria Pensotti, et al.
Journal of Mammary Gland Biology and Neoplasia|November 1, 2003
Breast cancer prevention trials using retinoidsAndrea Decensi, Davide Serrano, Bernardo Bonanni, et al.
Plos One|April 8, 2022
A randomized controlled trial comparing self-referred message to family-referred message promoting men's adherence to evidence-based guidelines on BRCA1/2 germline genetic testing: A registered study protocolSerena Petrocchi, Giulia Ongaro, Mariarosaria Calvello, et al.
Nature Clinical Practice. Oncology|January 30, 2007
Fenretinide and risk reduction of second breast cancerAndrea Decensi, Silvia Zanardi, Alessandra Argusti, et al.
Current Oncology (Toronto, Ont.)|April 21, 2022
Psychological Determinants of Men's Adherence to Cascade Screening for <i>BRCA1/2</i>Giulia Ongaro, Serena Petrocchi, Mariarosaria Calvello, et al.
American Journal of Men'S Health|August 7, 2025
Can Family Motivation Enhance Men's Uptake of Cascade Screening for Familial <i>BRCA1/2</i> Mutations?Giulia Ongaro, Serena Petrocchi, Mariarosaria Calvello, et al.
Pageof 27